Is Indaptus Therapeutics, Inc. (INDP) a Buy, Sell, or Hold?
NASDAQ : INDP
Indaptus Therapeutics, Inc.
$2.53 USD
$0 (0.0%)
- Volume
- 17.34K
- Average Volume
- 1.01M
- Market Capitalization
- $4.43M
- P/E Ratio
- -0.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $12.03
- Year Low
- $0.92
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.34
Company Overview
NASDAQ
Junyi Dai
Biotechnology
Healthcare
INDP
5
US
USD
Liquidity Metrics
0.00
2.34
2.34
1.61
0.00
Sales & Valuation
-$
0.00
4.39
-0.26
-7.97
Profitability
-$21.58
-$20.85M
0.00%
0.00%
-1028.81%
-864.69%
P/E Metrics
-0.40
0.00
0.00
Analyst Price Target & Rating
2/5
2 Analysts
%
Poll Results
No votes yet today — be the first to share your view!
About Indaptus Therapeutics, Inc. (NASDAQ:INDP) Stock
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in Augus ... t of the same year. Its corporate headquarters are situated in New York, New York.
Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders
2026-06-17 23:02:00
STAMFORD, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Indaptus Therapeutics, Inc. (Nasdaq: INDP) who held their shares prior to December 22, 2025.
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-15 07:00:00
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company, today announced financial results for the first quarter ended March 31, 2026, and provided a strategic corporate update. Junyi Dai, Indaptus Therapeutics' Chief Executive Officer and Chairman of the Board, commented, “Following recent changes in executive management, the Company has conducted a review of its development programs, operating resources and ongoing corporate initiatives.
Frequently Asked Questions
-
What is the current Indaptus Therapeutics, Inc. (INDP) stock price?
-
Indaptus Therapeutics, Inc.(NASDAQ:INDP) stock price is $2.53 in the last trading session. During the trading session, INDP stock reached the peak price of $12.029 while $0.92 was the lowest point it dropped to. The percentage change in INDP stock occurred in the recent session was 0.0% while the dollar amount for the price change in INDP stock was $0.
-
INDP's industry and sector of operation?
-
The NASDAQ listed INDP is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of INDP?
-
Yu Ding | Chief Financial Officer
Junyi Dai | CEO & Chairman
Michael J. Newman | Founder, Chief Scientific Officer & Director
Walt Addison Linscott | Chief Operating Officer
| -
How many employees does INDP have?
-
Number of INDP employees currently stands at 5. INDP operates from 3 Columbus Circle, New York City, NY 10019, US.
-
Link for INDP official website?
-
Official Website of INDP is: https://indaptusrx.com
-
How do I contact INDP?
-
INDP could be contacted at phone #347 480 9760 and can also be accessed through its website. INDP operates from 3 Columbus Circle, New York City, NY 10019, US.
-
How many shares of INDP are traded daily?
-
The average number of INDP shares traded daily for last 3 months was 1.01M.
-
What is the market cap of INDP currently?
-
The market value of INDP currently stands at $4.43M with its latest stock price at $2.53